Impact of payment reform on chemotherapy at the end of life

American Journal of Managed Care

Volumn 18, Issue 5, 2012, Pages

  Colla, Carrie H ^a   Morden, Nancy E ^a   Skinner, Jonathan S ^a,b,c   Hoverman, J Russell ^d   Meara, Ellen ^a  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^d TEXAS ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; COMORBIDITY; DEATH; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEMATOLOGIC MALIGNANCY; HOSPITAL DEPARTMENT; HUMAN; INCOME; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; METASTASIS; OUTPATIENT DEPARTMENT; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; TREATMENT DURATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CONFIDENCE INTERVALS; HEALTH CARE REFORM; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MEDICARE; NEOPLASMS; PROGNOSIS; REGRESSION ANALYSIS; TERMINAL CARE; UNITED STATES;

EID: 84864413721     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. US Government Accountability Office: Medicare chemotherapy payments: New drug and administration fees are closer to providers' costs. http://www.gao.gov/new.items/d05142r.pdf
2. Medicare Payment Advisory Commission: Report to the Congress: Effects of Medicare payment changes on oncology services. http://www.medpac.gov/documents/ Jan06-Oncology-mandated-report.pdf
3. Berenson A: Incentives limit any savings in treating cancer. New York Times, June 12, 2007. http://www.nytimes.com/2007/06/12/ business/12cancerpay. html
4. Akscin J, Barr TR, Towle EL: Key practice indicators in office-based oncology practices: 2007 report on 2006 data. J Oncol Pract 3:200-203, 2007 (Pubitemid 351593675)
5. Berenson A: Cancer drug representatives spelled out the way to profit. New York Times, June 12, 2007. http://www.nytimes.com/2007/06/12/business/ 12cancerside.html?-r=1&ref=business
6. Johnson A: In treating cancer, insurer tries new way to pay docs.Wall Street Journal, October 20, 2010. http://online.wsj.com/ articleSB10001424052702303550904575562440652409512.html?KEYWORDS=medicare
7. Harris G: Among cancer doctors, a Medicare revolt: New payment system spurs talk of return to hospital care and old drugs. New York Times, March 11, 2004. http://www.nytimes.com/2004/03/11/business/among-cancer-doctors-medicare- revolt-new-payment-system-spurstalk-return.html?pagewanted=all
8. Abelson R: Insurers test new cancer pay systems. New York Times, October 19, 2010:B1. http://www.nytimes.com/2010/10/20/health/policy/20cancer.html
9. Berenson A: Cancer drugs offer hope but at a huge expense. New York Times, July 12, 2005. http://www.nytimes.com/2005/07/12/business/12cancer.html? pagewanted=all
10. Berenson A: A stubborn case of spending on cancer care. New York Times, June 12, 2007:C1
11. Shahinian VB, Kuo YF, Gilbert SM: Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med 363: 1822-1832, 2010
12. Jacobson M, Earle CC, Price M, et al: How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) 29:1391-1399, 2010
13. Shea AM, Curtis LH, Hammill BG, et al: Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. JAMA 300:189-196, 2008 (Pubitemid 351969303)
14. Friedman JY, Curtis LH, Hammill BG, et al: The Medicare Modernization Act and reimbursement for outpatient chemotherapy: Do patients perceive changes in access to care? Cancer 110:2304-2312, 2007 (Pubitemid 350100753)
15. Earle CC, Neville BA, Landrum MB, et al: Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care 17:505-509, 2005 (Pubitemid 41762420)
16. Earle CC, Landrum MB, Souza JM, et al: Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? J Clin Oncol 26: 3860-3866, 2008
17. Emanuel EJ, Young-Xu Y, Levinsky NG, et al: Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 138:639-643, 2003
18. Jacobson M, O'Malley AJ, Earle CC, et al: Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) 25:437-443, 2006 (Pubitemid 43529552)
19. Hillman AL, Pauly MV, Kerstein JJ: How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations? N Engl J Med 321:86-92, 1989 (Pubitemid 19170397)
20. Jacobson JO, Neuss MN, McNiff KK, et al: Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative. J Clin Oncol 26:1893-1898, 2008
21. Iezzoni LI, Heeren T, Foley SM, et al: Chronic conditions and risk of in-hospital death. Health Serv Res 29:435-460, 1994 (Pubitemid 24326127)
22. Berke EM, Smith T, Song Y, et al: Cancer care in the United States: Identifying end-of-life cohorts. J Palliat Med 12:128-132, 2009
23. Miesfeldt S, Murray K, Chang CH, et al: Association of age, gender, and race with intensity of end-of-life care for Medicare beneficiaries with cancer. J Palliat Med (in press)
24. Earle CC, Ayanian JZ: Looking back from death: The value of retrospective studies of end-of-life care. J Clin Oncol 24:838-840, 2006 (Pubitemid 46638831)
25. Earle CC, Park ER, Lai B, et al: Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133-1138, 2003 (Pubitemid 46594144)
26. Wennberg JE, Skinner J, Goodman DC, et al: Tracking the Care of Patients With Chronic Illness: The Dartmouth Atlas of Health Care 2008. Lebanon, NH, Dartmouth Institute for Health Policy and Clinical Practice, 2008
27. US Census Bureau: Census 2000, American fact finder. http://factfinder. census.gov/servlet/DTGeoSearchByListServlet?ds-name=DEC-2000-SF3- U&-lang=en&-ts=283785721496
28. Dartmouth Institute of Health Policy and Clinical Practice: Primary care service area project 2009. http://pcsa.dartmouth.edu/index.html
29. White H: A heteroskedasticity-consistent covariance-matrix estimator and a direct test for heteroskedasticity. Econometrica 48:817-838, 1980
30. Bach PB, Cramer LD, Warren JL, et al: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198-1205, 1999 (Pubitemid 29480659)
31. Earle CC, Neville BA, Landrum MB, et al: Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-321, 2004 (Pubitemid 41095097)
32. MarketWatch: New poll: Doctors overwhelmingly support palliative care at end-of-life. Wall Street Journal, November 15, 2011
33. Bruera E, Sweeney C, Calder K, et al: Patient preferences versus physician perceptions of treatment decisions in cancer care. J Clin Oncol 19:2883-2885, 2001 (Pubitemid 32538198)
34. Robinson JC: Applying value-based insurance design to high-cost health services. Health Aff (Millwood) 29:2009-2016, 2010
35. Bach PB, Mirkin JN, Luke JJ: Episode-based payment for cancer care: A proposed pilot for Medicare. Health Aff (Millwood) 30:500-509, 2011
36. Fisher ES, McClellan MB, Bertko J, et al: Fostering accountable health care: Moving forward in medicare. Health Aff (Millwood) 28:w219-w231, 2009
37. McClellan M, McKethan AN, Lewis JL, et al: A national strategy to put accountable care into practice. Health Aff (Millwood) 29:982-990, 2010